Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Harnessing network pharmacology and in silico drug discovery to uncover new targets and therapeutics for Alzheimer's disease

5 Feb 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholinesterase and Neurodegenerative Diseases
Share to Computational Drug Discovery Methods
Share to Nuclear Receptors and Signaling

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39914200
DOI: 10.1016/j.compbiomed.2025.109781

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Harnessing network pharmacology and in silico drug discovery to uncover new targets and therapeutics for Alzheimer's diseasePMID 39914200Read ↗

Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s diseaseSemantic proximity Read ↗

Network pharmacology and bioinformatics approach reveals the therapeutic mechanism of action of curcumin in Alzheimer diseaseSemantic proximity Read ↗

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read ↗

Key Regulators of Alzheimer’s Disease: Network Biology and In-Silico Analysis with AChE and Glutamate InhibitorsSemantic proximity Read ↗

Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer’s DiseaseSemantic proximity Read ↗

Network Medicine and Alzheimer’s Disease TherapySemantic proximity Read ↗

Network Pharmacology Unveils Potential Targets of Madhuca longifolia in Treating Alzheimer’s Disease: An Advanced Strategy in Drug DiscoverySemantic proximity Read ↗

A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer diseaseSemantic proximity Read ↗

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer’s DiseaseSemantic proximity Read ↗

Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer’s Disease: Insights from a Synaptic Machinery PerspectiveSemantic proximity Read ↗

Network pharmacology and bioinformatics approach reveals the therapeutic activity and action mechanism of curcumin in Alzheimer diseaseSemantic proximity Read ↗

Connecting the dots: applications of network medicine in pharmacology and disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.